Unaudited Standalone Financial Results of the Company for the Quarter and half Year Ended on 30th September, 2025.

Net loss reportedNegative operating cash flowDebt to equity above the thresholdGoing-concern doubtResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Reaction day

₹12.78

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-4.8% vs market

Pharmaceuticals peers, median of 157sector-0.0%-4.9% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 4.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.9-0.1-4.8-0.0-4.9

Next day

-8.5-0.2-8.3-0.4-8.0

-12.8+0.4-13.2-0.3-12.4

-17.1-0.4-16.7-1.0-16.0

-21.0-0.6-20.4-1.3-19.7

-24.4-0.9-23.5-1.5-22.9

—-3.0—-3.3—

15d

—-3.9—-3.4—

-37.6-4.8-32.7-4.0-33.5

-16.7-7.8-8.9-6.6-10.0

—-7.2—-8.7—

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Adline Chem Lab Ltd reported weak unaudited results for Q2/H1 FY26. Total income stood at just ₹24.99 lakhs for H1 FY26 (with no revenue in the comparable prior periods shown), against total expenses of about ₹13.89 lakhs. The company posted a loss before tax of ₹13.89 lakhs for H1 FY26 and a loss after tax of ₹12.21 lakhs, widening from the prior half year. The balance sheet is deeply stressed: other equity is negative at ₹(746.41) lakhs versus share capital of ₹585 lakhs, putting net worth at roughly ₹(161) lakhs, with non-current borrowings of ₹164.95 lakhs. Operating cash flow was negative at ₹(9.50) lakhs for the half year. The statutory auditor (Jain Kedia & Sharma) issued an unmodified limited review report. Separately, Managing Director Sarang Pathak and Non-Executive Director Hemant Parikh resigned with effect from close of business on November 12, 2025, and Vrushank Patel was appointed as the new Chairman.

Likely market impact

This is a negative filing for shareholders — the company continues to report losses, is operating with negative net worth and persistent cash burn, and now faces a top-level leadership transition. The stock is likely to remain under pressure, and small investors should weigh the going-concern-type risk profile carefully.